Global Pulmonary Function Testing Systems Market size was valued at USD 2.3 Bn in 2022 and is expected to reach USD 3.53 Bn by 2029, at a CAGR of 6.3%. Overview The pulmonary Function Testing System is a device that performs Pulmonary Function Tests including, Spirometry, Lung volume, Plehysmography and others. These devices have been used for utilization by people suffering from severe breathing issues such as asthma, restrictive lung diseases and COPD. The report provides a thorough analysis of segments and sub-segments in local, global and regional markets. The report provides information on drivers, restraints, and macro variables affect local, global and regional Systems of market. It contains a comprehensive analysis of the global Pulmonary Function Testing Systems market's trends, forecasts, and monetary values. The report includes primary and secondary collection techniques with qualitative and quantitative approaches for the analysis of the Pulmonary Function Testing Systems Market.To know about the Research Methodology :- Request Free Sample Report
Pulmonary Function Testing Systems Market Dynamics
Drivers Increasing Prevalence of Respiratory Diseases to Boost the Market Growth Asthma, COPD, pneumonia, tuberculosis and lung cancer are the more prominent respiratory disease. Asthma is caused due to the exposure of air pollutants including tobacco smoke and allergies, environmental factors, genetics and respiratory infections. Approximately 300 million people currently have asthma and its prevalence increases by 50% every decade. 10% of the population in North America have the Asthma. Chronic obstructive pulmonary disease (COPD) is a lung disease causing due to breathing problems and restricted airflow and people who suffer from COPD their lungs have damaged with phlegm. Approximately 14.8 Mn people in the United States have been diagnosed with COPD and more than 25 Mn people suffer from asthma. The Pulmonary Function Testing Systems type measures human breathing to support health care providers’ diagnosis as well as monitor asthma. Spirometry is the test that confirms the diagnosis and establishes COPD staging. As a result, the Pulmonary Function Testing Systems are more useful for the diagnosis of respiratory disease and thus increasing the prevalence of respiratory diseases boosts the Pulmonary Function Testing Systems Market growth. Technological Advancements in Pulmonary Function Testing Systems to Fuel the market growth Pulmonary Function Testing is a non-invasive test that shows how well the lungs are working. In the system of Pulmonary Function Testing, there has been the introduction of many advanced tests which leads to providing the integration of systems of Pulmonary Function Testing. The Spirometry, Pulmonary Rehabilitation, TB & MDR TB, ILD Clinic, Airway Clinic, Home ventilation, Video Bronchoscopy, Endobronchial Ultrasound, Body Box and Single breath Diffusion system,Sleep disorder clinic and Sleep Laboratory, Skin prick Allergy test, Immunotherapy Drug Allergy Testing and Thoracoscopy and management of Pleural Disorders are the advanced lungs tests and facilities of the lung function tests. For example. Bronchoscopy is an advanced video bronchoscopy system and is well-equipped with endoscopy suites with trained technicians. The current intervention in the Bronchoscopy are Bronchial lavage, Biopsy, Airway dilatation and stenting with electrocautery and APC. Bronchoscopy helps to remove foreign bodies from the airway. Another one is the Body box lung function test which is a cost-effective test used to diagnose early lung diseases such as COPD, Obesity with obstruction and Early ILD. As a result, the technological advances in Pulmonary Function Testing Systems boost the Pulmonary Function Testing Systems industry growth.Pulmonary Function Testing Systems Market Restraints
In Pulmonary Function Testing System, the Pulmonary Function Testing causes several risks such as dizziness during tests, feeling short of breath, coughing and trouble breathing from injury to the chest which causes allergies. Spirometry has various limitations such as the demonstration of the airflow limitation and it has not determined the causes such as airway obstruction and decreased muscle strength. Pulmonary Function Testing is not applicable for persons that have gone from recent eye surgery, belly or chest surgery. As a result, the increase in the risks of Pulmonary Function Testing impedes the Pulmonary Function Testing Systems industry.Pulmonary Function Testing Systems Market Segment Analysis
By Type On the basis of the System type, the market is segmented into complete PFT Systems and Portable PFT Systems. The complete PFT systems dominated with largest Pulmonary Function Testing Systems Market in 2022 and are expected to grow the market over the forecast period. It includes lung function tests, Spirometry which measure lung volume, gas measures and capacity and it takes around one and a half hours. The growing number of hospitals that need complete Pulmonary Function Testing systems and the increasing number of the population which suffers from COPD and asthma increase the visits the hospitals are the growth drivers for the segment growth.By Application Based on the Application, the Pulmonary Function Testing Systems market is divided into Chronic Obstructive Pulmonary Disorder, Asthma, Chronic Shortness of Breath, Restrictive Lung Diseases and Others. The asthma segment held the market with the largest market revenue in 2022. To help healthcare providers diagnose and monitor asthma, the lung function test is used to measure human breathing .Chronic Obstructive Pulmonary Disorder is expected to dominate the market over the forecast period. The Spirometry is the most useful type of Pulmonary Function Testing System and is largely used to diagnose COPD and Pulmonary Function Testing Systems measure lung volume, capacity, rates of flow and gas exchange.
By End Users On the basis of the End Users, the market is categorized into Hospitals, Specialty Clinics, Diagnostic Laboratories and Others. The hospital segment held the Pulmonary Function Testing Systems’ largest Pulmonary Function Testing Systems Market share in 2022 and is expected to continue its dominance during the forecast period. The segment is driven by the increasing use of Pulmonary Function Testing Systems for the diagnosis of patients in hospitals and the availability of a broad range of the. Patients who are suffering from respiratory diseases such as asthma and COPD have been visiting the hospitals many times.
Pulmonary Function Testing Systems Market Regional Insights
North America held the Pulmonary Function Testing Systems Market with the largest revenue and is expected to continue its dominance during the forecast period. The regional market is driven by the increase in the prevalence of chronic respiratory diseases, the rising geriatric population and the increase in the use of the Pulmonary Function Testing Systems. American Lung Association is the non [profit organization that works to save lives by improving lung health with many Pulmonary Functions Testing Such as spirometry, Bronchoscopy and they also support sources to help countless Americans manage lung diseases, such as asthma and COPD. Thus, this association helps to grow the regional Pulmonary Function Testing Systems Market. The United States is the major market for Pulmonary Function Testing Systems and helps to drive regional market growth. The technological advancements in the diagnosis process and increasing penetration in the use of Pulmonary Function Testing Systems are the market growth drivers in the United States. Europe is expected to grow significantly Pulmonary Function Testing Systems Market during the forecast period. The improvement in the healthcare infrastructure and the increasing number of the population who suffers from asthma and COPD and the presence of the key players are the influencing factors for the regional market growth.Pulmonary Function Testing Systems Market Competitive Landscape
The Competitive Landscape of the Pulmonary Function Testing Systems market covers the number of key companies, company size, their strengths, weaknesses, barriers and threats. The key players have adopted the strategies such as pricing investments, expansion of the product portfolio, mergers and acquisition collaboration, agreements and geographical expansion for the enhancement of the Pulmonary Function Testing Systems industry. Some of the Pulmonary Function Testing Systems key players in the Pulmonary Function Testing Systems are ndd Medizintechnik AG, COSMED srl, MGC Diagnostics Corporation, PulmOne Advancd Medical Devices, CHEST M.I., Inc, VYAIRE MEDICAL,INC., KoKo PFT, Medical Electronic Construction, Morgan Scientific Inc, Minato Medical Science Co Ltd and others. The companies have developed new Pulmonary Function Testing machines which are helpful to reduce the problems of people who suffer from respiratory diseases. PulmOne Advanced Medical Devices: The MiniBox is a, cabinless, portable, pulmonary function test (PFT) machine used for easy testing of Spirometry and Lung Volumes. It is ideal for the clinician as well as the patient due to its fully automatic measurements and short testing time. Many companies adopted and researched new techniques of the Pulmonary Function Testing Systems Medizintechnik AG: EasyOne Pro provides the most efficient and accurate way to test lung function in various settings. Thier patented TrueFlow and TrueCheck technology used by the engineers. This technique eliminates all common sources of error, saves time and offers patients the best pulmonary care lung function lab.Pulmonary Function Testing Systems Market Scope: Inquire before buying
Pulmonary Function Testing Systems Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 2.3 Bn. Forecast Period 2023 to 2029 CAGR: 6.3 % Market Size in 2029: US $ 3.53 Bn. Segments Covered: by Product Type Handheld Tabletop by System Type Portable PFT Systems Complete PFT Systems by Test Type Spirometry Plethysmography Nitrogen Washout Lung Volume Gas Exchange Testing Maximize Voluntary Ventilation Oxygen titration Test Exercise Stress Test Others by Component Hardware Software Services by Application Chronic Obstructive Pulmonary Disorder Asthma Chronic Shortness of Breath Restrictive Lung Diseases Others by End Use Hospitals Specialty Clinics Diagnostic Laboratories Others Brick and Mortar E-commerce by Distribution Channel Brick and Mortar E-commerce Pulmonary Function Testing Systems Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Pulmonary Function Testing Systems Key Player
1. ndd Medizintechnik AG 2. COSMED srl 3. MGC Diagnostics corporation 4. PulmOne Advancd Medical Devices 5. CHEST M.I., Inc 6. VYAIRE MEDICAL,INC. 7. KoKo PFT 8. Medical Electronic Construction 9. Morgan Scientific Inc 10. Minato Medical Science Co Ltd 11. Schiller Ag 12. Medical Equipment Europe GmbH 13. NSPIRE HEALTH INC. 14. Koninklijke Philips N.V. 15. Omron Healthcare InC. 16. 3M 17. Ganshorn Medizin Electronic 18. Data Science International 19. Medline Industries Frequently Asked Questions: 1] What is the growth rate of the Global Pulmonary Function Testing Systems Market? Ans. The Global Pulmonary Function Testing Systems Market is growing at a significant rate of 6.3 % during the forecast period. 2] Which region is expected to dominate the Global Pulmonary Function Testing Systems Market? Ans. North America is expected to dominate the Pulmonary Function Testing Systems Market during the forecast period. 3] What is the expected Global Pulmonary Function Testing Systems Market size by 2029? Ans. The Pulmonary Function Testing Systems Market size is expected to reach USD 3.53 Bn by 2029. 4] Which are the top players in the Global Pulmonary Function Testing Systems Market? Ans. The major top players in the Global Pulmonary Function Testing Systems Market are ndd Medizintechnik AG, COSMED srl, MGC Diagnostics corporation, PulmOne Advancd Medical Devices, CHEST M.I., Inc, VYAIRE MEDICAL,INC., KoKo PFT, Medical Electronic Construction, Morgan Scientific Inc, Minato Medical Science Co Ltd and others. 5] What are the factors driving the Global Pulmonary Function Testing Systems Market growth? Ans. technological advancements in pulmonary function testing systems and increasing prevalence of respiratory diseases are expected to drive market growth during the forecast period.
1. Pulmonary Function Testing Systems Market: Research Methodology 2. Pulmonary Function Testing Systems Market: Executive Summary 3. Pulmonary Function Testing Systems Market: Competitive Landscape 3.1. MMR Competition Matrix 3.2. Competitive Landscape 3.3. Key Players Benchmarking 3.4. Market Structure 3.4.1. Market Leaders 3.4.2. Market Followers 3.4.3. Emerging Players 3.5. Consolidation of the Market 4. Pulmonary Function Testing Systems Market: Dynamics 4.1. Market Trends by Region 4.1.1. North America 4.1.2. Europe 4.1.3. Asia Pacific 4.1.4. Middle East and Africa 4.1.5. South America 4.2. Market Drivers by Region 4.2.1. North America 4.2.2. Europe 4.2.3. Asia Pacific 4.2.4. Middle East and Africa 4.2.5. South America 4.3. Market Restraints 4.4. Market Opportunities 4.5. Market Challenges 4.6. PORTER’s Five Forces Analysis 4.7. PESTLE Analysis 4.8. Value Chain Analysis 4.9. Regulatory Landscape by Region 4.9.1. North America 4.9.2. Europe 4.9.3. Asia Pacific 4.9.4. Middle East and Africa 4.9.5. South America 5. Pulmonary Function Testing Systems Market Size and Forecast by Segments (by Value USD) 5.1. Pulmonary Function Testing Systems Market Size and Forecast, by Product Type (2022-2029) 5.1.1. Handheld 5.1.2. Tabletop 5.2. Pulmonary Function Testing Systems Market Size and Forecast, by System Type (2022-2029) 5.2.1. Portable PFT Systems 5.2.2. Complete PFT Systems 5.3. Pulmonary Function Testing Systems Market Size and Forecast, by Test Type (2022-2029) 5.3.1. Spirometry 5.3.2. Plethysmography 5.3.3. Nitrogen Washout 5.3.4. Lung Volume 5.3.5. Gas Exchange Testing 5.3.6. Maximize Voluntary Ventilation 5.3.7. Oxygen titration Test 5.3.8. Exercise Stress Test 5.3.9. Others 5.4. Pulmonary Function Testing Systems Market Size and Forecast, by Component (2022-2029) 5.4.1. Hardware 5.4.2. Software 5.4.3. Services 5.5. Pulmonary Function Testing Systems Market Size and Forecast, by Application (2022-2029) 5.5.1. Chronic Obstructive Pulmonary Disorder 5.5.2. Asthma 5.5.3. Chronic Shortness of Breath 5.5.4. Restrictive Lung Diseases 5.5.5. Others 5.6. Pulmonary Function Testing Systems Market Size and Forecast, by End Use (2022-2029) 5.6.1. Hospitals 5.6.2. Specialty Clinics 5.6.3. Diagnostic Laboratories 5.6.4. Others 5.7. Pulmonary Function Testing Systems Market Size and Forecast, by Distribution Channel (2022-2029) 5.7.1. Brick and Mortar 5.7.2. E-commerce 5.8. Pulmonary Function Testing Systems Market Size and Forecast, by Region (2022-2029) 5.8.1. North America 5.8.2. Europe 5.8.3. Asia Pacific 5.8.4. Middle East and Africa 5.8.5. South America 6. North America Pulmonary Function Testing Systems Market Size and Forecast (by Value USD) 6.1. North America Pulmonary Function Testing Systems Market Size and Forecast, by Product Type (2022-2029) 6.1.1. Handheld 6.1.2. Tabletop 6.2. North America Pulmonary Function Testing Systems Market Size and Forecast, by System Type (2022-2029) 6.2.1. Portable PFT Systems 6.2.2. Complete PFT Systems 6.3. North America Pulmonary Function Testing Systems Market Size and Forecast, by Test Type (2022-2029) 6.3.1. Spirometry 6.3.2. Plethysmography 6.3.3. Nitrogen Washout 6.3.4. Lung Volume 6.3.5. Gas Exchange Testing 6.3.6. Maximize Voluntary Ventilation 6.3.7. Oxygen titration Test 6.3.8. Exercise Stress Test 6.3.9. Others 6.4. North America Pulmonary Function Testing Systems Market Size and Forecast, by Component (2022-2029) 6.4.1. Hardware 6.4.2. Software 6.4.3. Services 6.5. North America Pulmonary Function Testing Systems Market Size and Forecast, by Application (2022-2029) 6.5.1. Chronic Obstructive Pulmonary Disorder 6.5.2. Asthma 6.5.3. Chronic Shortness of Breath 6.5.4. Restrictive Lung Diseases 6.5.5. Others 6.6. North America Pulmonary Function Testing Systems Market Size and Forecast, by End Use (2022-2029) 6.6.1. Hospitals 6.6.2. Specialty Clinics 6.6.3. Diagnostic Laboratories 6.6.4. Others 6.7. North America Pulmonary Function Testing Systems Market Size and Forecast, by Distribution Channel (2022-2029) 6.7.1. Brick and Mortar 6.7.2. E-commerce 6.8. North America Pulmonary Function Testing Systems Market Size and Forecast, by Country (2022-2029) 6.8.1. United States 6.8.2. Canada 6.8.3. Mexico 7. Europe Pulmonary Function Testing Systems Market Size and Forecast (by Value USD) 7.1. Europe Pulmonary Function Testing Systems Market Size and Forecast, by Product Type (2022-2029) 7.1.1. Handheld 7.1.2. Tabletop 7.2. Europe Pulmonary Function Testing Systems Market Size and Forecast, by System Type (2022-2029) 7.2.1. Portable PFT Systems 7.2.2. Complete PFT Systems 7.3. Europe Pulmonary Function Testing Systems Market Size and Forecast, by Test Type (2022-2029) 7.3.1. Spirometry 7.3.2. Plethysmography 7.3.3. Nitrogen Washout 7.3.4. Lung Volume 7.3.5. Gas Exchange Testing 7.3.6. Maximize Voluntary Ventilation 7.3.7. Oxygen titration Test 7.3.8. Exercise Stress Test 7.3.9. Others 7.4. Europe Pulmonary Function Testing Systems Market Size and Forecast, by Component (2022-2029) 7.4.1. Hardware 7.4.2. Software 7.4.3. Services 7.5. Europe Pulmonary Function Testing Systems Market Size and Forecast, by Application (2022-2029) 7.5.1. Chronic Obstructive Pulmonary Disorder 7.5.2. Asthma 7.5.3. Chronic Shortness of Breath 7.5.4. Restrictive Lung Diseases 7.5.5. Others 7.6. Europe Pulmonary Function Testing Systems Market Size and Forecast, by End Use (2022-2029) 7.6.1. Hospitals 7.6.2. Specialty Clinics 7.6.3. Diagnostic Laboratories 7.6.4. Others 7.7. Europe Pulmonary Function Testing Systems Market Size and Forecast, by Distribution Channel (2022-2029) 7.7.1. Brick and Mortar 7.7.2. E-commerce 7.8. Europe Pulmonary Function Testing Systems Market Size and Forecast, by Country (2022-2029) 7.8.1. UK 7.8.2. France 7.8.3. Germany 7.8.4. Italy 7.8.5. Spain 7.8.6. Sweden 7.8.7. Austria 7.8.8. Rest of Europe 8. Asia Pacific Pulmonary Function Testing Systems Market Size and Forecast (by Value USD) 8.1. Europe Pulmonary Function Testing Systems Market Size and Forecast, by Product Type (2022-2029) 8.1.1. Handheld 8.1.2. Tabletop 8.2. Asia Pacific Pulmonary Function Testing Systems Market Size and Forecast, by System Type (2022-2029) 8.2.1. Portable PFT Systems 8.2.2. Complete PFT Systems 8.3. Asia Pacific Pulmonary Function Testing Systems Market Size and Forecast, by Test Type (2022-2029) 8.3.1. Spirometry 8.3.2. Plethysmography 8.3.3. Nitrogen Washout 8.3.4. Lung Volume 8.3.5. Gas Exchange Testing 8.3.6. Maximize Voluntary Ventilation 8.3.7. Oxygen titration Test 8.3.8. Exercise Stress Test 8.3.9. Others 8.4. Asia Pacific Pulmonary Function Testing Systems Market Size and Forecast, by Component (2022-2029) 8.4.1. Hardware 8.4.2. Software 8.4.3. Services 8.5. Asia Pacific Pulmonary Function Testing Systems Market Size and Forecast, by Application (2022-2029) 8.5.1. Chronic Obstructive Pulmonary Disorder 8.5.2. Asthma 8.5.3. Chronic Shortness of Breath 8.5.4. Restrictive Lung Diseases 8.5.5. Others 8.6. Asia Pacific Pulmonary Function Testing Systems Market Size and Forecast, by End Use (2022-2029) 8.6.1. Hospitals 8.6.2. Specialty Clinics 8.6.3. Diagnostic Laboratories 8.6.4. Others 8.7. Asia Pacific Pulmonary Function Testing Systems Market Size and Forecast, by Distribution Channel (2022-2029) 8.7.1. Brick and Mortar 8.7.2. E-commerce 8.8. Asia Pacific Pulmonary Function Testing Systems Market Size and Forecast, by Country (2022-2029) 8.8.1. China 8.8.2. S Korea 8.8.3. Japan 8.8.4. India 8.8.5. Australia 8.8.6. Indonesia 8.8.7. Malaysia 8.8.8. Vietnam 8.8.9. Taiwan 8.8.10. Bangladesh 8.8.11. Pakistan 8.8.12. Rest of Asia Pacific 9. Middle East and Africa Pulmonary Function Testing Systems Market Size and Forecast (by Value USD) 9.1. Middle East and Africa Pulmonary Function Testing Systems Market Size and Forecast, by Product Type (2022-2029) 9.1.1. Handheld 9.1.2. Tabletop 9.2. Middle East and Africa Pulmonary Function Testing Systems Market Size and Forecast, by System Type (2022-2029) 9.2.1. Portable PFT Systems 9.2.2. Complete PFT Systems 9.3. Middle East and Africa Pulmonary Function Testing Systems Market Size and Forecast, by Test Type (2022-2029) 9.3.1. Spirometry 9.3.2. Plethysmography 9.3.3. Nitrogen Washout 9.3.4. Lung Volume 9.3.5. Gas Exchange Testing 9.3.6. Maximize Voluntary Ventilation 9.3.7. Oxygen titration Test 9.3.8. Exercise Stress Test 9.3.9. Others 9.4. Middle East and Africa Pulmonary Function Testing Systems Market Size and Forecast, by Component (2022-2029) 9.4.1. Hardware 9.4.2. Software 9.4.3. Services 9.5. Middle East and Africa Pulmonary Function Testing Systems Market Size and Forecast, by Application (2022-2029) 9.5.1. Chronic Obstructive Pulmonary Disorder 9.5.2. Asthma 9.5.3. Chronic Shortness of Breath 9.5.4. Restrictive Lung Diseases 9.5.5. Others 9.6. Middle East and Africa Pulmonary Function Testing Systems Market Size and Forecast, by End Use (2022-2029) 9.6.1. Hospitals 9.6.2. Specialty Clinics 9.6.3. Diagnostic Laboratories 9.6.4. Others 9.7. Middle East and Africa Pulmonary Function Testing Systems Market Size and Forecast, by Distribution Channel (2022-2029) 9.7.1. Brick and Mortar 9.7.2. E-commerce 9.8. Middle East and Africa Pulmonary Function Testing Systems Market Size and Forecast, by Country (2022-2029) 9.8.1. South Africa 9.8.2. GCC 9.8.3. Egypt 9.8.4. Nigeria 9.8.5. Rest of ME&A 10. South America Pulmonary Function Testing Systems Market Size and Forecast (by Value USD) 10.1. South America Pulmonary Function Testing Systems Market Size and Forecast, by Product Type (2022-2029) 10.1.1. Handheld 10.1.2. Tabletop 10.2. South America Pulmonary Function Testing Systems Market Size and Forecast, by System Type (2022-2029) 10.2.1. Portable PFT Systems 10.2.2. Complete PFT Systems 10.3. South America Pulmonary Function Testing Systems Market Size and Forecast, by Test Type (2022-2029) 10.3.1. Spirometry 10.3.2. Plethysmography 10.3.3. Nitrogen Washout 10.3.4. Lung Volume 10.3.5. Gas Exchange Testing 10.3.6. Maximize Voluntary Ventilation 10.3.7. Oxygen titration Test 10.3.8. Exercise Stress Test 10.3.9. Others 10.4. South America Pulmonary Function Testing Systems Market Size and Forecast, by Component (2022-2029) 10.4.1. Hardware 10.4.2. Software 10.4.3. Services 10.5. South America Pulmonary Function Testing Systems Market Size and Forecast, by Application (2022-2029) 10.5.1. Chronic Obstructive Pulmonary Disorder 10.5.2. Asthma 10.5.3. Chronic Shortness of Breath 10.5.4. Restrictive Lung Diseases 10.5.5. Others 10.6. South America Pulmonary Function Testing Systems Market Size and Forecast, by End Use (2022-2029) 10.6.1. Hospitals 10.6.2. Specialty Clinics 10.6.3. Diagnostic Laboratories 10.6.4. Others 10.7. South America Pulmonary Function Testing Systems Market Size and Forecast, by Distribution Channel (2022-2029) 10.7.1. Brick and Mortar 10.7.2. E-commerce 10.8. South America Pulmonary Function Testing Systems Market Size and Forecast, by Country (2022-2029) 10.8.1. Brazil 10.8.2. Argentina 10.8.3. Rest of South America 11. Company Profile: Key players 11.1. ndd Medizintechnik 11.1.1. Company Overview 11.1.2. Financial Overview 11.1.3. Business Portfolio 11.1.4. SWOT Analysis 11.1.5. Business Strategy 11.1.6. Recent Developments 11.2. ndd Medizintechnik AG 11.3. COSMED srl 11.4. MGC Diagnostics corporation 11.5. PulmOne Advancd Medical Devices 11.6. CHEST M.I., Inc 11.7. VYAIRE MEDICAL,INC. 11.8. KoKo PFT 11.9. Medical Electronic Construction 11.10. Morgan Scientific Inc 11.11. Minato Medical Science Co Ltd 11.12. Schiller Ag 11.13. Medical Equipment Europe GmbH 11.14. NSPIRE HEALTH INC. 11.15. Koninklijke Philips N.V. 11.16. Omron Healthcare InC. 11.17. 3M 11.18. Ganshorn Medizin Electronic 11.19. Data Science International 11.20. Medline Industries 12. Key Findings 13. Industry Recommendation